NDC 0008-1222

PristiqExtended-Release 100 mg tablet, extended release

On the label: Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc..

Ireland: 2Singapore: 1

Where it's made

FactoryWhereRoleLast FDA inspection
Pfizer Asia Manufacturing Pte LtdSingapore, SingaporeMakes the active ingredient and tests it Problems found, fixed voluntarilyOct 18, 2023 · 6 inspections
Pfizer Ireland Pharmaceuticals Unlimited CompanyNewbridge, IrelandMakes it, tests it, packages it and labels it Problems found, fixed voluntarilySep 23, 2022 · 8 inspections
Pfizer Ireland Pharmaceuticals Unlimited CompanyRingaskiddy, IrelandMakes the active ingredient and tests it Problems found, fixed voluntarilyOct 25, 2024 · 6 inspections
Pfizer Manufacturing Deutschland GmbHFreiburg im Breisgau, GermanyTests it, packages it and labels it Problems found, fixed voluntarilyJul 2, 2025 · 8 inspections
Pharmacia & Upjohn Company LLCKalamazoo, MI, United StatesLabels it Problems found, fixed voluntarilyJun 16, 2023 · 9 inspections
Wyeth Pharmaceutical Division of Wyeth Holdings LLCPearl River, NY, United StatesTests it Problems found, fixed voluntarilyDec 17, 2025 · 3 inspections

Recalls

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug
Desvenlafaxine: every company that makes it
Form
tablet, extended release, oral
Strength
100 mg
Approval
NDA NDA021992
On the market since
May 1, 2008
Package NDCs
0008-1222-01 0008-1222-14 0008-1222-30 0008-1222-50
Official label
DailyMed (National Library of Medicine), updated Apr 28, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?